
1. febs lett. 2013 jan 4;587(1):37-43. doi: 10.1016/j.febslet.2012.11.022. epub 2012
nov 28.

overexpression inactive tetherin delgpi mutant inhibits hiv-1 vpu-mediated
antagonism endogenous tetherin.

lv m(1), wang j, zhu y, wang x, zuo t, liu d, zhang j, wu j, zhang h, kong w, yu 
x.

author information: 
(1)national engineering laboratory aids vaccine, college life science,
jilin university, changchun, jilin province, people's republic china.

tetherin/bst-2/cd317 inhibits hiv-1 release infected cells, viral
vpu protein efficiently antagonizes antiviral activity direct
interaction transmembrane (tm) domains protein. here, we
demonstrated overexpression inactive tetherin delgpi mutant, tm
domain could competitively block vpu targeting endogenous tetherin,
potently inhibited hiv-1 release human tetherin-positive cells both
transient stable expression conditions. results also suggest that
heterologous dimerization occurred delgpi mutant endogenous
tetherin. findings suggest blocking vpu/tetherin interface may 
a novel therapeutic approach hiv-1 release.

copyright Â© 2012 federation european biochemical societies. published by
elsevier b.v. rights reserved.

doi: 10.1016/j.febslet.2012.11.022 
pmid: 23201263  [indexed medline]

